U.K. National External Quality Assessment Service (UK NEQAS)
UK NEQAS is a UK-registered charitable consortium founded in 1969 that delivers accredited External Quality Assessment (EQA) programmes across 100+ pathology disciplines to over 2,500 clinical laboratories in 53+ countries worldwide.
- Company typePrivate
- Founded1969
- HeadquartersSheffield, United Kingdom
- Headcount251–500
- GTM typeB2B
- OfferingServices
What U.K. National External Quality Assessment Service (UK NEQAS) does
UK NEQAS is a registered UK charity (Charity No. 1044013) and charitable consortium founded in 1969, headquartered in Sheffield, that provides External Quality Assessment (EQA) services to clinical and diagnostic laboratories worldwide. The consortium is composed of specialised centres hosted by NHS Foundation Trusts and public-health bodies — including Birmingham Quality (Clinical Chemistry), UK NEQAS for Microbiology (UKHSA, London), Blood Coagulation (Sheffield Teaching Hospitals), Trace Elements (Royal Surrey, Guildford), and GenQA (Edinburgh Bioquarter) — delivering more than 100 unique EQA schemes across clinical chemistry, haematology, microbiology, immunology, genomics, cellular pathology, reproductive science, transfusion, and parasitology.
The operating model combines periodic distribution of proficiency-testing specimens to participating laboratories (transported under IATA regulations) with web-based results-entry portals and performance reports. All member centres operate to ISO/IEC 17043:2010 accreditation, with UKAS proficiency testing provider accreditation held by individual centres. Differentiated products include PrepQ, a web-based pre- and post-analytical quality monitoring service using sigma metrics, and a Point-of-Care Testing EQA portfolio. Over 2,500 laboratories across 53+ countries participate, and UK NEQAS was commissioned in 2020 as the EQA provider for the NHS England Genomic Medicine Service.
Revenue is generated primarily through recurring EQA membership and participation fees paid by laboratories, supplemented by paid educational webinars, masterclasses, and scientific meetings. Pathology Quality Assessment (PQA) operates as a wholly-owned trading subsidiary for promotional and educational trading activity. As a not-for-profit, UK NEQAS does not publicly disclose financials. Marketing and distribution are direct-to-laboratory, supplemented by content marketing, social media, scientific publications, and conferences.
U.K. National External Quality Assessment Service (UK NEQAS) firmographics
Firmographics- Name
- U.K. National External Quality Assessment Service (UK NEQAS)
- Legal name
- United Kingdom National External Quality Assessment Service (UK NEQAS)
- Website
- https://ukneqas.org.uk
- Company type
- Private
- Founded year
- 1969
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- UK NEQAS is a UK-registered charitable consortium founded in 1969 that delivers accredited External Quality Assessment (EQA) programmes across 100+ pathology disciplines to over 2,500 clinical laboratories in 53+ countries worldwide.
- Ownership category
- akta.pro rank
U.K. National External Quality Assessment Service (UK NEQAS) industry classification
Industry- Product category
- External Quality Assessment Services
- NAICS
- Testing Laboratories and Services (54138), Medical Laboratories (621511), Other Scientific and Technical Consulting Services (541690)
- SIC
- Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
- akta.pro primary industry
- Laboratory Quality Systems, Accreditation & Proficiency Testing Programs (HLAJAIAM)
Keywords
Where U.K. National External Quality Assessment Service (UK NEQAS) is headquartered
LocationHeadquarters
- HQ city
- Sheffield
- HQ country
- United Kingdom
- HQ region
- Europe
Offices6 records
Markets served
U.K. National External Quality Assessment Service (UK NEQAS) business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
Revenue model
- EQA Membership and Participation Fees: UK NEQAS operates as a not-for-profit charitable consortium. Laboratories pay membership/participation fees to join EQA programs. The PrepQ service is provided as a benefit of UK NEQAS membership. Some invoices may be raised against PQA (Pathology Quality Assessment, the trading subsidiary) for educational meetings.
- Educational Events and Workshops: Revenue generated from educational workshops, masterclasses, and webinars. Events such as IHC webinars are priced at £110-175 for participants and non-participants (excluding VAT).
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | IHC Applications in Laboratory Practice Webinar - Participant rate |
| Other | Multi-year contract | IHC Applications in Laboratory Practice Webinar - Non-participant rate |
| Other | Multi-year contract | IHC Technical Issues and Quality Assurance Webinar - Participant rate |
| Other | Multi-year contract | IHC Technical Issues and Quality Assurance Webinar - Non-participant rate |
| Other | Multi-year contract | Epigenetics Webinar - Participant rate |
| Other | Multi-year contract | Epigenetics Webinar - Non-participant rate |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels7 records
U.K. National External Quality Assessment Service (UK NEQAS) product offering
Product offeringCore offering
UK NEQAS operates as a charitable consortium providing External Quality Assessment (EQA) schemes that distribute proficiency-testing specimens to clinical laboratories worldwide, enabling independent benchmarking of diagnostic performance across 100+ testing areas in clinical chemistry, haematology, microbiology, genomics, immunology, and other pathology disciplines. Participating laboratories submit results through dedicated web portals and receive performance reports compared against peers using sigma metrics. The portfolio is complemented by the proprietary PrepQ pre- and post-analytical quality monitoring service, Point of Care Testing EQA programmes, and supporting educational resources including webinars, masterclasses, and learning materials.
Product overview
UK NEQAS is a charitable consortium of External Quality Assessment (EQA) providers offering a comprehensive portfolio of quality assessment services for clinical laboratories. The organisation operates across multiple disciplines including Immunology and Allergy, Cellular Pathology, Clinical Biochemistry, Haematology, Transfusion and Transplantation, Genetics, Virology, and Microbiology. The core offering consists of EQA programmes covering over 100 unique testing areas, supplemented by specialised modules such as PrepQ for pre- and post-analytical quality monitoring, and Point of Care Testing (POCT) EQA. Educational services including webinars, masterclasses, and learning resources support participant training. All schemes operate within a harmonised quality management system aligned to ISO/IEC 17043:2010 standards.
Differentiator
Problem solved
Functional benefit
Brands
- GenQA (Genomics Quality Assessment): Provides external quality assessment for clinical genomics services covering patient counselling, sample preparation, testing processes, results interpretation and reporting.
- Birmingham Quality
- PrepQ
- UK NEQAS for Microbiology
Products and services
- UK NEQAS EQA Programmes A comprehensive portfolio of external quality assessment schemes covering all clinical laboratory disciplines, including Blood Coagulation, Blood Transfusion Laboratory Practice, Cardiac Markers, Cellular Pathology Technique, Clinical Chemistry, Edinburgh and Guildford Peptide Hormones, Genomics (GenQA), Haematology, Histocompatibility & Immunogenetics, Immunocytochemistry & ISH, Immunology IIA, Leucocyte Immunophenotyping, Microbiology, Parasitology, Reproductive Science, and Trace Elements. Designed for clinical and diagnostic laboratories needing ISO/IEC 17043-accredited proficiency testing.
- PrepQ Pre and Post-Analytical Quality Monitoring Service
Quantifiable outcome
- 95% of clinical pathways rely on pathology services using UK NEQAS quality assurance
- +2 more outcomes
Companies that use U.K. National External Quality Assessment Service (UK NEQAS)
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles4 records
U.K. National External Quality Assessment Service (UK NEQAS) technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
U.K. National External Quality Assessment Service (UK NEQAS) partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- NHS EnglandcoreUK NEQAS has been commissioned as the EQA provider for the NHS England Genomic Medicine Service, supporting the world-leading genomic testing program across NHS services.
Scale indicators8 records
Recent moves6 records
Expansion highlights5 records
U.K. National External Quality Assessment Service (UK NEQAS) competitors and assessment
Company assessmentDirect peers
- QCMD (Quality Control for Molecular Diagnostics): Scotland-based EQA provider focused on molecular diagnostics and infectious disease testing, overlapping with UK NEQAS's microbiology and genomics programmes and targeting the same global clinical laboratory customer base.
- Labquality: Finnish EQA and proficiency testing organisation offering external quality assessment schemes across clinical laboratory disciplines, serving Nordic and European laboratories as a direct competitor to UK NEQAS.
- Referenzinstitut für Bioanalytik (RfB): German reference institute for bioanalytics that runs proficiency testing schemes in clinical chemistry and laboratory medicine, a direct European EQA peer to UK NEQAS with overlapping scheme coverage.
- INSTAND e.V. German-based non-profit proficiency testing provider offering EQA schemes across clinical chemistry, haematology, microbiology, immunology, and molecular diagnostics, directly competing with UK NEQAS in continental Europe and beyond.
- College of American Pathologists (CAP): CAP operates the CAP Laboratory Accreditation Program and runs proficiency testing/external quality assessment schemes (Surveys) that directly compete with UK NEQAS's core EQA programmes across clinical pathology disciplines, serving laboratories globally.
- ECAT (External Quality Control for Assays and Tests): Netherlands-based EQA provider running proficiency testing for coagulation, haematology, and other disciplines, directly overlapping with UK NEQAS Blood Coagulation and Haematology schemes and serving European laboratories.
- OneWorld Accuracy: Canada-based EQA provider offering proficiency testing programmes across multiple laboratory disciplines globally, competing directly with UK NEQAS for international laboratory customers outside the UK.
Regional players
- qualab (Swiss Quality Control Association): Swiss national EQA organisation running mandatory external quality controls across clinical laboratory disciplines in Switzerland, comparable to UK NEQAS's domestic role but geographically restricted to Switzerland.
- RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs): Australia-based EQA provider run by the Royal College of Pathologists of Australasia, offering proficiency testing across pathology disciplines primarily in the Asia-Pacific region and a regional peer to UK NEQAS's Asia-Pacific participants.
Others
- EQALM (European Organisation for External Quality Assurance Providers in Laboratory Medicine): European umbrella organisation coordinating EQA providers including UK NEQAS; not a direct competitor but an industry body and strategic stakeholder in shaping EQA standards and accreditation in Europe.
Market position
Strengths5 records
Weaknesses4 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
U.K. National External Quality Assessment Service (UK NEQAS) social profiles
Digital presenceU.K. National External Quality Assessment Service (UK NEQAS) compliance and trust
Trust signalCompliance4 records
U.K. National External Quality Assessment Service (UK NEQAS) financial estimates
Financial estimateRevenue estimate
Valuation estimate
U.K. National External Quality Assessment Service (UK NEQAS) leadership team
Management profileNumber of profiles
Profiles13 records
U.K. National External Quality Assessment Service (UK NEQAS) subsidiaries and ownership
Company hierarchySubsidiaries1 record
U.K. National External Quality Assessment Service (UK NEQAS) funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
U.K. National External Quality Assessment Service (UK NEQAS) M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about U.K. National External Quality Assessment Service (UK NEQAS)
What does U.K. National External Quality Assessment Service (UK NEQAS) do?
UK NEQAS operates as a charitable consortium providing External Quality Assessment (EQA) schemes that distribute proficiency-testing specimens to clinical laboratories worldwide, enabling independent benchmarking of diagnostic performance across 100+ testing areas in clinical chemistry, haematology, microbiology, genomics, immunology, and other pathology disciplines. Participating laboratories submit results through dedicated web portals and receive performance reports compared against peers using sigma metrics. The portfolio is complemented by the proprietary PrepQ pre- and post-analytical quality monitoring service, Point of Care Testing EQA programmes, and supporting educational resources including webinars, masterclasses, and learning materials.
Is U.K. National External Quality Assessment Service (UK NEQAS) a public or private company?
U.K. National External Quality Assessment Service (UK NEQAS) is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was U.K. National External Quality Assessment Service (UK NEQAS) founded?
U.K. National External Quality Assessment Service (UK NEQAS) was founded in 1969. It employs 251 to 500 people.
Where is U.K. National External Quality Assessment Service (UK NEQAS) based?
U.K. National External Quality Assessment Service (UK NEQAS) is headquartered in Sheffield, United Kingdom, in the Europe region.
How does U.K. National External Quality Assessment Service (UK NEQAS) make money?
Two revenue lines are on record. EQA Membership and Participation Fees are the primary driver. The others are educational Events and Workshops.
Who are U.K. National External Quality Assessment Service (UK NEQAS)'s main competitors?
Direct peers on record are QCMD (Quality Control for Molecular Diagnostics), Labquality, Referenzinstitut für Bioanalytik (RfB), INSTAND e.V., College of American Pathologists (CAP), ECAT (External Quality Control for Assays and Tests) and OneWorld Accuracy. Regional players are qualab (Swiss Quality Control Association) and RCPAQAP (Royal College of Pathologists of Australasia Quality Assurance Programs). EQALM (European Organisation for External Quality Assurance Providers in Laboratory Medicine) is listed as an others.
Does U.K. National External Quality Assessment Service (UK NEQAS) have an API?
No public API is recorded for U.K. National External Quality Assessment Service (UK NEQAS).
What industry is U.K. National External Quality Assessment Service (UK NEQAS) in?
U.K. National External Quality Assessment Service (UK NEQAS)'s product category is External Quality Assessment Services. Its primary akta.pro industry code is HLAJAIAM, Laboratory Quality Systems, Accreditation & Proficiency Testing Programs. Its NAICS code is 54138 and its SIC code is 8071.